POSTOPERATIVE PULMONARY TOXICITY ASSOCIATED WITH MITOMYCIN-C THERAPY

摘要: As more patients survive cancer, and as sophisticated multidrug antineoplastic protocols are developed, the chances of an anesthesiologist's coming into contact with who have been treated such increasing. The anesthesiologist must administer anesthesia to a patient has had chemotherapy be cognizant particular agents that potential for producing occult pulmonary dysfunction. Anesthetic management these cases carefully planned titrated prevent further lung injury.